The use and impact of European Testing Week regional awareness campaigns to increase HIV and viral hepatitis testing coverage

被引:2
|
作者
Raben, Dorthe [1 ]
Kahama, C. B. [1 ]
Combs, L. [1 ]
Stengaard, Annemarie [1 ]
Rockstroh, J. K. [2 ]
Simoes, Daniel [3 ]
Collins, Ben [4 ]
European Testing Week Working Grp
EuroTEST Steering Committee
机构
[1] Univ Copenhagen, CHIP, Rigshosp, Copenhagen, Denmark
[2] Univ Hosp Bonn, Dept Med 1, Bonn, Germany
[3] CoalitionPLUS, Paris, France
[4] ReShape Int HIV Partnerships, London, England
关键词
awareness; campaign; hepatitis; HIV; testing;
D O I
10.1111/hiv.13544
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
IntroductionSince 2013, the European Testing Week (ETW) awareness campaign has become a key regional event influencing testing efforts for HIV, viral hepatitis, and sexually transmitted infections (STIs) through participation of 720 organizations. Here, we report on a survey from May to June 2022 aimed at assessing the participant-reported impact of the campaign.MethodsAll past and current participating organizations were asked to complete an online questionnaire between 12 May and 17 June 2022. Multiple choice and open-text questions included organization information, usage of ETW to engage in local testing-related activities, and the effect of a regional campaign to reach a wider audience and generate impact.ResultsOf the 52 respondents, 34 (65%) stated first participating in ETW 5-10 years ago. ETW was used for awareness raising by 40 respondents (83%), new testing activities by 37 (77%), advocacy initiatives by 15 (31%), and training/capacity building by 18 (38%). For awareness raising, 95% used ETW to highlight the importance of and to encourage testing; for new testing activities, 74% used ETW to reach new groups. In total, 44 (85%) reported added benefits of a Europe-wide campaign compared with national/local campaigns, particularly the increased visibility and collaboration opportunities. Impact at the local level was observed by 24 (51%), and impact at a national level was observed by 20 (43%). A total of 28 (79%) reported increases in the number of tests performed and 25 (75%) reported increases in clients accessing services.ConclusionsRegional awareness campaigns reach wider audiences, boost local and national efforts to increase testing, and sensitize key populations about the critical value of testing compared with local/national campaigns.
引用
收藏
页码:154 / 160
页数:7
相关论文
共 50 条
  • [31] Testing for hepatitis B virus alone does not increase vaccine coverage in non-immunized persons
    Anders Boyd
    Julie Bottero
    Fabrice Carrat
    Jo?l Gozlan
    Hayette Rougier
    Pierre-Marie Girard
    Karine Lacombe
    World Journal of Gastroenterology, 2017, 23 (38) : 7037 - 7046
  • [32] Testing for hepatitis B virus alone does not increase vaccine coverage in non-immunized persons
    Boyd, Anders
    Bottero, Julie
    Carrat, Fabrice
    Gozlan, Joel
    Rougier, Hayette
    Girard, Pierre-Marie
    Lacombe, Karine
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (38) : 7037 - 7046
  • [33] Awareness of KRAS testing by oncologists and panitumumab use in colorectal cancer patients: A European survey
    Trojan, Jorg
    Taylor, Aliki
    Terwey, Jan-Henrik
    Downey, Gerry
    Kafatos, George
    Alfonso, Pilar Garcia
    Tomasek, Jiri
    Mineur, Laurent
    van Krieken, Han
    Aprile, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [34] EMCDDA publishes guidelines on testing for HIV, viral hepatitis and other infections in injecting drug users
    Wiessing, L.
    Blystad, H.
    EUROSURVEILLANCE, 2010, 15 (48): : 22 - 22
  • [35] A call to action toward integrated testing and earlier care for viral hepatitis, HIV, STIs and TB
    Raben, D.
    Hoekstra, M.
    Combs, L.
    Sullivan, A. K.
    Lazarus, J., V
    Lambert, Js
    Simoes, D.
    Streinu-Cercel, A.
    Rockstroh, J. K.
    HIV MEDICINE, 2020, 21 (06) : 403 - 408
  • [36] Viral hepatitis in HIV-positive patients - testing, prophylaxis and treatment in Central and Eastern Europe
    Kase, K.
    Skrzat-Klapaczynska, A.
    Matulionyte, R.
    Mulabdic, V.
    Bukovinova, P.
    Vassilenko, A.
    Bolokadze, N.
    Jilich, D.
    Antoniak, S.
    Oprea, C.
    Balayan, T.
    Harxhi, A.
    Papadopoulos, A.
    Lakatos, B.
    Vasylyev, M.
    Babic, J. Simonovic
    Begovac, J.
    Yancheva, N.
    Streinu-Cercel, A.
    Verhaz, A.
    Gokengin, D.
    Lukic, G. Dragovic
    Horban, A.
    HIV MEDICINE, 2019, 20 : 270 - 271
  • [37] Testing the impact of geopolitics on European democratic countries' soft power use
    Trunkos, Judit
    JOURNAL OF POLITICAL POWER, 2022, 15 (03) : 532 - 555
  • [38] Innovating the Model for Student Pharmacists to Increase Access to Hepatitis C Testing (Project IMPACT)
    Januszka, Jenna
    Notarianni, Victoria
    Devenny, Elissa
    Harris, Elizabeth
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (04) : 1217 - 1221
  • [39] European Recommendations for the Clinical Use of HIV Drug Resistance Testing: 2011 Update
    Vandamme, Anne-Mieke
    Camacho, Ricardo J.
    Ceccherini-Silberstein, Francesca
    de Luca, Andrea
    Palmisano, Lucia
    Paraskevis, Dimitrios
    Paredes, Roger
    Poljak, Mario
    Schmit, Jean-Claude
    Soriano, Vincent
    Walter, Hauke
    Sonnerborg, Anders
    AIDS REVIEWS, 2011, 13 (02) : 77 - 108
  • [40] NOVEL USE OF VENUE-SPECIFIC CODES TO TRACK IMPACT OF A CAMPAIGN TO INCREASE AWARENESS AND USE OF AN ONLINE HIV/STI TESTING SERVICE (GETCHECKEDONLINE) AMONG GAY AND BISEXUAL MEN IN VANCOUVER, CANADA
    Salway, Travis
    Kwag , Michael
    Edward, Joshua
    Haag, Devon
    Bondyra, Mark
    Grace, Daniel
    Cox, Joseph
    Moore, David
    Trussler, Terry
    Hart, Trevor
    Shannon, Kate
    Shoveller, Jean
    Ogilvie, Gina
    Gilbert, Mark
    SEXUALLY TRANSMITTED INFECTIONS, 2017, 93 : A15 - A15